Receptor News and Research

RSS

Study identifies gene that influences risk of obesity in adulthood

The importance of good nutrition in the early development of children has been recognized for many decades. Nutritional experiences in early life can have profound and long-lasting effects on body weight in later life.

13 Mar 2018

Groundbreaking discoveries pave way for fast-acting antidote to tackle cholera epidemics

Groundbreaking discoveries regarding the onset of cholera are paving the way for a future, fast-acting antidote for cholera epidemics, according to research published in the journals PLOS Pathogens and ACS Infectious Disease.

9 Mar 2018

Boosting the brain's immune cells may prevent or reduce severity of Alzheimer's disease

Sanford Burnham Prebys Medical Research Institute researchers have published two new studies in Neuron that describe how TREM2, a receptor found on immune cells in the brain, interacts with toxic amyloid beta proteins to restore neurological function.

8 Mar 2018

Researchers reveal new molecular target to help ease asthma symptoms

Researchers at UC Davis Health and Albany Medical College have shown that the protein vascular endothelial growth factor A -- or VEGFA -- plays a major role in the inflammation and airway obstruction associated with asthma.

7 Mar 2018

New suggests different approach to eczema treatment

Eczema affects about 17 percent of children in developed countries and is often the gateway to food allergy and asthma, initiating an "atopic march" toward broader allergic sensitization.

6 Mar 2018

New study identifies the body's 'glucostat'

It is the pancreatic islets that have the overall responsibility for maintaining normal blood glucose levels in our bodies, according to a new study by researchers at Karolinska Institutet in Sweden and the University of Miami Miller School of Medicine, USA.

6 Mar 2018

Salk researchers uncover power switch for muscles

If you've ever wondered how strenuous exercise translates into better endurance, researchers at the Salk Institute may have your answer. In a study published in the journal Cell Reports on March 6, 2018, scientists in Ronald Evans' lab have shown that the protein ERRγ (ERR gamma) helps deliver many of the benefits associated with endurance exercise.

6 Mar 2018

Gene-editing technology enhances T cell immunotherapies for treating cancer

Last year, the Food and Drug Administration approved the first cellular immunotherapies to treat cancer. These therapies involve collecting a patient's own immune cells -- called T cells -- and supercharging them to home in on and attack specific blood cancers, such as hard-to-treat acute lymphoblastic leukemia and non-Hodgkin lymphoma.

6 Mar 2018

NETRF awards six new research grants to improve treatments for neuroendocrine tumors

The Neuroendocrine Tumor Research Foundation today awarded six new research grants totaling $1.85 million to leading academic institutions around the world.

5 Mar 2018

Antibiotic use may affect efficacy of cancer immunotherapies

Antibiotic use is known to have a near-immediate impact on our gut microbiota and long-term use may leave us drug-resistant and vulnerable to infection.

2 Mar 2018

Gastric bypass can provide better outcomes for patients with obesity and diabetes than lifestyle intervention

People with worrisome levels of obesity and poor control of their type 2 diabetes face two dramatically different options to substantially improve their health: bariatric (weight loss) surgery or intensive lifestyle management.

2 Mar 2018

Blockade of a protein increases surveillance activity of blood-patrolling monocytes, study shows

Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), led by Dr. Alicia G. Arroyo, have identified a function of a protease that could be targeted for the treatment of some infections and even tumor metastasis.

2 Mar 2018

Nervous system can "put the brakes" on immune response and prevent excessive inflammation

Cells in the nervous system can "put the brakes" on the immune response to infections in the gut and lungs to prevent excessive inflammation, according to research by Weill Cornell Medicine scientists. This insight may one day lead to new ways to treat diseases caused by unchecked inflammation, such as asthma and inflammatory bowel disease.

2 Mar 2018

TSRI scientists discover new target for treating major depressive disorder

Scientists on the Florida campus of The Scripps Research Institute have discovered a new target for treating major depressive disorder, a disease that affects more than 16 million American adults.

1 Mar 2018

UH researcher examines role of estrogen in cervical cancer

Two University of Houston researchers, working to find cancer cures, received grants from the Cancer Prevention & Research Institute of Texas, the organization that funds groundbreaking cancer research and prevention programs in the state.

1 Mar 2018

Study finds Ramadan fasting to be safe for heart failure patients

Ramadan fasting can be safe for patients with heart failure, according to research presented today at the 29th Annual Conference of the Saudi Heart Association, held 1 to 3 March in Riyadh, Saudi Arabia.

1 Mar 2018

Unique progenitor cells in the pancreas have potential to develop glucose-responsive beta cells

Scientists from the Diabetes Research Institute at the University of Miami Miller School of Medicine have confirmed the existence of progenitor cells within the human pancreas that can be stimulated to develop into glucose-responsive beta cells.

28 Feb 2018

Pancreatic progenitor cells could be used to treat diabetes, suggests study

Researchers have confirmed the existence of progenitor cells in the pancreas that can be stimulated to turn into glucose-responsive beta cells.

28 Feb 2018

Receptors crucial for establishing strong memories

When we create a memory, a pattern of connections forms between neurons in the brain. New work from UC Davis shows how these connections can be strengthened or weakened at a molecular level. The study is published Feb. 27 in the journal Cell Reports.

27 Feb 2018

Celgene announces regulatory information about investigational compound for relapsing multiple sclerosis

Celgene Corporation today announced that it has received a Refusal to File letter from the United States Food and Drug Administration regarding its New Drug Application for ozanimod in development for the treatment of patients with relapsing forms of multiple sclerosis.

27 Feb 2018

Receptor News and Research

Study identifies gene that influences risk of obesity in adulthood

Groundbreaking discoveries pave way for fast-acting antidote to tackle cholera epidemics

Boosting the brain's immune cells may prevent or reduce severity of Alzheimer's disease

Researchers reveal new molecular target to help ease asthma symptoms

New suggests different approach to eczema treatment

New study identifies the body's 'glucostat'

Salk researchers uncover power switch for muscles

Gene-editing technology enhances T cell immunotherapies for treating cancer

NETRF awards six new research grants to improve treatments for neuroendocrine tumors

Antibiotic use may affect efficacy of cancer immunotherapies

Gastric bypass can provide better outcomes for patients with obesity and diabetes than lifestyle intervention

Blockade of a protein increases surveillance activity of blood-patrolling monocytes, study shows

Nervous system can "put the brakes" on immune response and prevent excessive inflammation

TSRI scientists discover new target for treating major depressive disorder

UH researcher examines role of estrogen in cervical cancer

Study finds Ramadan fasting to be safe for heart failure patients

Unique progenitor cells in the pancreas have potential to develop glucose-responsive beta cells

Pancreatic progenitor cells could be used to treat diabetes, suggests study

Receptors crucial for establishing strong memories

Celgene announces regulatory information about investigational compound for relapsing multiple sclerosis

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News